BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31584892)

  • 41. Intrauterine Manipulator Use During Minimally Invasive Hysterectomy and Risk of Lymphovascular Space Invasion in Endometrial Cancer.
    Machida H; Hom MS; Adams CL; Eckhardt SE; Garcia-Sayre J; Mikami M; Matsuo K
    Int J Gynecol Cancer; 2018 Feb; 28(2):208-219. PubMed ID: 29324541
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prevalence, characteristics, and risk factors of occult uterine cancer in presumed benign hysterectomy.
    Desai VB; Wright JD; Gross CP; Lin H; Boscoe FP; Hutchison LM; Schwartz PE; Xu X
    Am J Obstet Gynecol; 2019 Jul; 221(1):39.e1-39.e14. PubMed ID: 30853364
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaginal douching in Cambodian women: its prevalence and association with vaginal candidiasis.
    Heng LS; Yatsuya H; Morita S; Sakamoto J
    J Epidemiol; 2010; 20(1):70-6. PubMed ID: 20009371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A longitudinal study of vaginal douching and bacterial vaginosis--a marginal structural modeling analysis.
    Brotman RM; Klebanoff MA; Nansel TR; Andrews WW; Schwebke JR; Zhang J; Yu KF; Zenilman JM; Scharfstein DO
    Am J Epidemiol; 2008 Jul; 168(2):188-96. PubMed ID: 18503038
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.
    Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Manson JE; Li J; Harris TG; Rohan TE; Xue X; Ho GY; Einstein MH; Kaplan RC; Burk RD; Wylie-Rosett J; Pollak MN; Anderson G; Howard BV; Strickler HD
    Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):921-9. PubMed ID: 18398032
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Discussions of vaginal douching with family members.
    Short MB; Black WR; Flynn K
    J Pediatr Adolesc Gynecol; 2010 Feb; 23(1):39-44. PubMed ID: 19643647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endometrial carcinoma in the baby boomer generation. Tumor characteristics and clinical outcome.
    Elshaikh MA; Cattaneo R; Shah M; Patel S; Mahan M; Buekers T; Siddiqui F
    Anticancer Res; 2013 Feb; 33(2):619-24. PubMed ID: 23393357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recurrence, death, and secondary malignancy after ovarian conservation for young women with early-stage low-grade endometrial cancer.
    Matsuo K; Cripe JC; Kurnit KC; Kaneda M; Garneau AS; Glaser GE; Nizam A; Schillinger RM; Kuznicki ML; Yabuno A; Yanai S; Garofalo DM; Suzuki J; St Laurent JD; Yen TT; Liu AY; Shida M; Kakuda M; Oishi T; Nishio S; Marcus JZ; Adachi S; Kurokawa T; Ross MS; Horowitz MP; Johnson MS; Kim MK; Melamed A; Machado KK; Yoshihara K; Yoshida Y; Enomoto T; Ushijima K; Satoh S; Ueda Y; Mikami M; Rimel BJ; Stone RL; Growdon WB; Okamoto A; Guntupalli SR; Hasegawa K; Shahzad MMK; Im DD; Frimer M; Gostout BS; Ueland FR; Nagao S; Soliman PT; Thaker PH; Wright JD; Roman LD
    Gynecol Oncol; 2019 Oct; 155(1):39-50. PubMed ID: 31427143
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genital use of talc and risk of ovarian cancer: a meta-analysis.
    Berge W; Mundt K; Luu H; Boffetta P
    Eur J Cancer Prev; 2018 May; 27(3):248-257. PubMed ID: 28079603
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaginal douching among university women in the southeastern United States.
    Cottrell BH; Close FT
    J Am Coll Health; 2008; 56(4):415-21. PubMed ID: 18316286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Talc, body powder, and ovarian cancer: A summary of the epidemiologic evidence.
    Wentzensen N; O'Brien KM
    Gynecol Oncol; 2021 Oct; 163(1):199-208. PubMed ID: 34366148
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term Follow-up After Endometrial Ablation in Finland: Cancer Risks and Later Hysterectomies.
    Soini T; Rantanen M; Paavonen J; Grénman S; Mäenpää J; Pukkala E; Gissler M; Hurskainen R
    Obstet Gynecol; 2017 Sep; 130(3):554-560. PubMed ID: 28796675
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Diagnosis of human papillomavirus infection by abnormal cervical cytology is highly reproducible after vaginal douching.
    Chen FC; Shaw SW; Cheng PJ; Hsueh S; Lin CT
    Taiwan J Obstet Gynecol; 2008 Dec; 47(4):412-6. PubMed ID: 19126507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of frequent douchers attending a community clinic primarily serving African-American women.
    Smith LV; Rudy ET; Ivie SD; Lee D; Visscher B; Kerndt P
    J Natl Med Assoc; 2005 Oct; 97(10):1386-92. PubMed ID: 16353660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Douching, pelvic inflammatory disease, and incident gonococcal and chlamydial genital infection in a cohort of high-risk women.
    Ness RB; Hillier SL; Kip KE; Richter HE; Soper DE; Stamm CA; McGregor JA; Bass DC; Rice P; Sweet RL
    Am J Epidemiol; 2005 Jan; 161(2):186-95. PubMed ID: 15632269
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
    Farrell R; Dixon SC; Carter J; Webb PM
    Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perineal talc exposure and risk of ovarian carcinoma.
    Chang S; Risch HA
    Cancer; 1997 Jun; 79(12):2396-401. PubMed ID: 9191529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
    Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sleep duration and the risk of endometrial cancer incidence among Japanese women: A pooled analysis of the Miyagi Cohort Study and the Ohsaki Cohort Study.
    Sugawara Y; Lu Y; Kanemura S; Fukao A; Tsuji I
    Cancer Epidemiol; 2023 Oct; 86():102427. PubMed ID: 37480621
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers.
    Lee YC; Milne RL; Lheureux S; Friedlander M; McLachlan SA; Martin KL; Bernardini MQ; Smith C; Picken S; Nesci S; Hopper JL; Phillips KA;
    Eur J Cancer; 2017 Oct; 84():114-120. PubMed ID: 28802188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.